QALSODY® (tofersen)| Official Patient site
QALSODY® (tofersen) is a prescription medicine used to treat adults with amyotrophic lateral sclerosis (ALS) who have a mutation, or change, in the superoxide dismutase 1 (SOD1) gene. …
Tofersen - Wikipedia
Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). [2] Tofersen is an antisense oligonucleotide that targets …
FDA approves treatment of amyotrophic lateral sclerosis …
FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS). Qalsody …
- [PDF]
QALSODY
QALSODY is an antisense oligonucleotide indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide...
Qalsody: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年5月22日 · Qalsody (tofersen) is a prescription medicine used to treat amyotrophic lateral sclerosis (ALS) in adults who have a specific genetic mutation in the superoxide dismutase 1 …
Qalsody - European Medicines Agency (EMA)
2024年2月23日 · Qalsody is a medicine for treating adults with a type of amyotrophic lateral sclerosis (ALS) caused by a mutation (defect) in the gene responsible for producing an …
Qalsody(tofersen)中文说明书-价格-适应症-不良反应及注意事项
2024年4月9日 · 2023年4月25日，美国食品药品监督管理局(FDA)宣布已经加速批准Biogen公司的Qalsody(tofersen，100mg/15ml)注射液用于治疗具有超氧化物歧化酶1(SOD1)突变的肌萎缩 …
QALSODY(tofersen)用于SOD1-肌萎缩侧索硬化症中文说明书|香港 …
QALSODY是一种 反义寡核苷酸，适用于治疗超氧化物歧化酶1（SOD1）基因突变的成人肌萎缩侧索硬化症（ALS）。 基于在接受QALSODY治疗的患者中观察到的血浆神经丝轻链减少，该适 …
QALSODY is an antisense oligonucleotide indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide...
Drug Trials Snapshots: QALSODY - FDA
QALSODY is an antisense oligonucleotide (ASO) that treats adults with amyotrophic lateral sclerosis (ALS) who have a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1 …